Moderna, Inc. (MRNA) 在今日夜盘时段股价大跌5.05%，引发了市场关注。
消息面上，Moderna首席执行官斯蒂芬·班塞尔在接受采访时表示，由于美国官员对免疫接种的反对态度日益增强，公司不打算投资新的后期疫苗试验。他指出，监管延迟和政府层面的不支持使得市场规模“小得多”，并强调“如果不能进入美国市场，你就无法获得投资回报”。
此外，美国卫生与公众服务部部长已采取行动修改疫苗政策，包括取消对特定人群的COVID-19疫苗接种建议、限制疫苗强制规定，并削减了对mRNA疫苗研究的资助。这些政策变化直接影响了Moderna的核心业务前景，导致市场对其未来增长潜力产生担忧，从而在夜盘交易中引发股价下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.